Medicare 'Fraud' Crackdown: Protecting Profits, Not Patients
📰 THE STORY: The Hill's opinion piece warns that a new Medicare policy aimed at reducing fraud, specifically targeting 'complex rehabilitation technology' (CRT) for wheelchair users, could inadvertently harm patients by making it harder for them to access essential, customized equipment. The policy requires prior authorization for certain CRT devices, which advocates fear will create bureaucratic
hurdles and delays for those in critical need. 🔍 WHAT THEY'RE NOT TELLING YOU: Historical Context: This 'fraud' narrative is a classic playbook to justify austerity measures in social programs. Think back to the Reagan era's demonization of 'welfare queens' in the 1980s that paved the way for drastic cuts to social safety nets. The focus on individual 'fraudsters' conveniently deflects from the
systemic, legal fraud perpetrated by major pharmaceutical companies and hospital systems that routinely price-gouge and overbill with impunity. Double Standard: The media frets over potential Medicare fraud from a wheelchair vendor while largely ignoring the billions siphoned off by private insurance companies, their exorbitant administrative costs, and the obscene profits of pharmaceutical
giants. Where are the op-eds condemning the '$7 billion stolen' by pharma through price gouging, as documented by organizations like Patients for Affordable Drugs? When Big Pharma 'defrauds' the public, it's called 'business strategy'; when a small clinic is suspected, it's 'a national crisis.' Follow the Money: The call for tighter regulations almost always benefits the biggest players who can